
Pregabalin (165mg)
Active composition
Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels, inhibiting excitatory neurotransmitter release and reducing neuronal excitability.
Medical applications
Gabawin-ER 165 Tablet contains Pregabalin 165mg, an anticonvulsant and neuropathic pain agent used primarily to manage conditions such as epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. Pregabalin works by binding to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, which reduces the release of several neurotransmitters involved in pain and seizure activity. Gabawin-ER 165 is an extended-release formulation designed to provide a consistent therapeutic effect over an extended period, improving patient compliance by reducing dosing frequency. It is commonly prescribed to control partial-onset seizures in adults and to alleviate nerve pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, and spinal cord injury. Additionally, it helps in managing fibromyalgia symptoms and generalized anxiety disorder. Patients should take Gabawin-ER 165 exactly as prescribed, usually once daily, with or without food. Common side effects may include dizziness, somnolence, dry mouth, edema, blurred vision, and weight gain. It is important to avoid abrupt discontinuation to prevent withdrawal symptoms. Gabawin-ER 165 should be used cautiously in patients with renal impairment and those with a history of substance abuse. Always consult a healthcare professional before starting or stopping this medication.
Cyclic GABA Analogues
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Gabawin-ER 165 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Gabawin-ER 165 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Gabawin-ER 165 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Gabawin-ER 165 Tablet may be needed. Please consult your doctor.
Exercise Caution
Gabawin-ER 165 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Gabawin-ER 165 Tablet is safe to use in patients with liver disease. No dose adjustment of Gabawin-ER 165 Tablet is recommended.
Regular Checkup
0 reviews for Gabawin-ER 165 Tablet

Pregabalin (165mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels, inhibiting excitatory neurotransmitter release and reducing neuronal excitability.
Medical applications
Gabawin-ER 165 Tablet contains Pregabalin 165mg, an anticonvulsant and neuropathic pain agent used primarily to manage conditions such as epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. Pregabalin works by binding to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, which reduces the release of several neurotransmitters involved in pain and seizure activity. Gabawin-ER 165 is an extended-release formulation designed to provide a consistent therapeutic effect over an extended period, improving patient compliance by reducing dosing frequency. It is commonly prescribed to control partial-onset seizures in adults and to alleviate nerve pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, and spinal cord injury. Additionally, it helps in managing fibromyalgia symptoms and generalized anxiety disorder. Patients should take Gabawin-ER 165 exactly as prescribed, usually once daily, with or without food. Common side effects may include dizziness, somnolence, dry mouth, edema, blurred vision, and weight gain. It is important to avoid abrupt discontinuation to prevent withdrawal symptoms. Gabawin-ER 165 should be used cautiously in patients with renal impairment and those with a history of substance abuse. Always consult a healthcare professional before starting or stopping this medication.
Cyclic GABA Analogues
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Gabawin-ER 165 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Gabawin-ER 165 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Gabawin-ER 165 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Gabawin-ER 165 Tablet may be needed. Please consult your doctor.
Exercise Caution
Gabawin-ER 165 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Gabawin-ER 165 Tablet is safe to use in patients with liver disease. No dose adjustment of Gabawin-ER 165 Tablet is recommended.
Regular Checkup
0 reviews for Gabawin-ER 165 Tablet















